Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
08/2010
08/04/2010CN101795670A Liquid formulation of G-CSF
08/04/2010CN101792763A Antisense oligonucleotide for specifically adjusting POKEMON gene expression and application thereof
08/04/2010CN101792762A Antisense oligonucleotide for specifically adjusting POKEMON gene expression and application thereof
08/04/2010CN101792752A Metarginase and recombination expression method and use thereof
08/04/2010CN101792493A Method for preparing spreading hedyotis herb polysaccharide
08/04/2010CN101792484A Anthracycline derivative of polypeptide containing tyrosine-isoleucine-glycine-serine-arginine
08/04/2010CN101792477A Acetyl ursolic acid acylate triethanolamine monoester with anti-cancer activity and preparation method thereof
08/04/2010CN101792449A Raubasine derivative, preparation and application thereof
08/04/2010CN101792448A Nacyline derivative, preparation and application
08/04/2010CN101792444A Sodium levofolinate and preparation method and drug combination thereof
08/04/2010CN101792401A Biphenyl compound with anti-tumor activity and preparation method thereof
08/04/2010CN101792375A Sesquiterpene compound in tobacco stems and preparation method and application thereof
08/04/2010CN101791411A Preparation and application of amphiphilic polysaccharide conjugate and medicinal compositions thereof
08/04/2010CN101791409A peptide vectors
08/04/2010CN101791396A Controlled release compositions for interferon based on PEGT/PBT block copolymers
08/04/2010CN101791394A Hydroxyamidine and hydroxyguanidine compounds as urokinase inhibitors
08/04/2010CN101791379A Traditional Chinese medicine compound oral preparation for preventing and treating tumor diseases
08/04/2010CN101791371A Method for preparing saponin by extracting asparagus officinalis L
08/04/2010CN101791366A Method for testing quality of Discorea nipponica Makino in different places and medicinal materials of same genera
08/04/2010CN101791363A Broad spectrum anticancer vegetable drug, preparation method and application thereof
08/04/2010CN101791343A Traditional Chinese medicine for treating tumor of digestive tract, strengthening body resistance and removing summer-heat
08/04/2010CN101791332A Compound gingko health product solid preparation
08/04/2010CN101791326A Method for extracting and purifying flavonoids of artemisia argyi
08/04/2010CN101791325A Preparation method of Chinese goosebeery capsule for preventing and treating lung cancer
08/04/2010CN101791315A Compound monoammonium glycyrrhizinate S pharmaceutical composition and method for preparing high-capacity injection
08/04/2010CN101791308A Combinations comprising epothilones and pharmaceutical uses thereof
08/04/2010CN101791307A Application of 2-imino-phenylate-5-(2-hydroxy-benzyl)-1,3-thiazole-4-ketone in preparing anti-cerebral cancer medicaments
08/04/2010CN101791306A Salinosporamides and methods for use thereof
08/04/2010CN101791295A Compound monoammonium glycyrrhizinate S pharmaceutical composition and method for preparing frozen powder injection
08/04/2010CN101791293A Allicin liposome for resisting microbe, protozoan and tumor and preparation method thereof
08/04/2010CN101791288A Stable lenalidomide oral solid preparation
08/04/2010CN101317823B Implantation type antineoplastic drug of 10-hydroxycamptothecin dual-sustained-release particle formulation and preparation method thereof
08/04/2010CN101230081B Extraction method for separating antineoplastic tri-terpenoid from capsule of weeping forsythia and use thereof
08/04/2010CN101016319B Benzoisoselenothiazolidone aminosugar derivative, preparing method and application therheof
08/04/2010CN101015551B Preparing method of triptolide stereoscopic stable liposome nano granule
08/04/2010CN101007050B Extract of an traditional Chinese medicine containing isopsoralen, preparation method and use thereof
08/04/2010CN101006860B Smoke-roasting bamboo salt and its making method
08/03/2010US7767790 Apotosis inducing viral protein, in combination with defective p53 protein, for use in treatment of cell proliferative and autoimmune disorders
08/03/2010US7767787 Substance for obtaining highly effective tumor medications as well as a process
08/03/2010US7767693 inhibition of heat shock protein 90 (HSP90) comprising administering benzoyl compounds or prodrugs,as antitumor agents
08/03/2010US7767679 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
08/03/2010US7767675 Imidazotriazines and imidazopyrimidines as kinase inhibitors
08/03/2010US7767672 Aminopyrimidines useful as kinase inhibitors
08/03/2010US7767670 Substituted 3-carboxamido isoxazoles as kinase modulators
08/03/2010US7767669 inhibitors of phosphatidyl inositol (PI) 3-kinase, such as 4-(1H-indazol-5-ylamino)-6- (4-methoxy-3- methylphenyl)-2-morpholin- 4-ylpyrimidine-5-carboxylic acid, used for the treatment of breast cancer
08/03/2010US7767663 Soluble 17-amino-analogs of geldanamycin in acid addition salt form; water solubility; anticancer agents; storage stability
08/03/2010US7767659 Synthesis of naturally occurring ecteinascidins and related compounds
08/03/2010US7767456 Non-viral gene delivery system
08/03/2010US7767429 use to treat glycosaminoglycan associated pathologies such as eye disorders or tumors; sialated and pegylated forms of a recombinant sHASEGP to enhance stability and serum pharmacokinetics over naturally occurring slaughterhouse enzymes; transgenic animals; dosage forms; HYLENEX RECOMBINANT tradename
08/03/2010US7767392 Nucleotide sequences coding zinc finger protein for use in identifying modulators of cell proliferation disorders; antitumor agents
08/03/2010US7767208 Noninvasive vascular therapy
08/03/2010US7767207 Interleukin-18 specific immunoglobulins for treatment and prevention of autoimmune, respiratory, reproductive, heart, connective tissue, liver, bone and arthritic disorders
08/03/2010CA2512926C Methods and compositions for inhibition of angiogenesis
08/03/2010CA2459311C 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
08/03/2010CA2444269C Treatment of disorders secondary to organic impairments
08/03/2010CA2409828C Formulation based in heparin, glycosaminoglycan or heparinoid, use of the formulation and the formulation base
08/03/2010CA2402199C Amidino compounds useful as nitric oxide synthase inhibitors
08/03/2010CA2306343C Novel aryloxy-alkyl-dialkylamines
08/03/2010CA2247247C Troponin subunits and fragments useful as angiogenesis inhibitors
08/03/2010CA2188813C Angiostatin protein, nucleic acids encoding the same and methods of detection
07/2010
07/29/2010WO2010085651A1 In vivo photodynamic therapy of cancer via a near infrared agent encapsulated in calcium phosphate nanoparticles
07/29/2010WO2010085597A1 Macrocyclic compounds and their use as kinase inhibitors
07/29/2010WO2010085588A2 Modulating angiogenesis
07/29/2010WO2010085570A1 Poly (ADP-Ribose) Polymerase (PARP) Inhibitors
07/29/2010WO2010085462A1 Method for treating triple negative breast cancer
07/29/2010WO2010085377A2 Hydroxamic acid derivatives
07/29/2010WO2010084999A1 Immunosuppressive agents and prophylactic and therapeutic agents for autoimmune diseases
07/29/2010WO2010084767A1 N-substituted saturated heterocyclic sulfone compounds with cb2 receptor agonistic activity
07/29/2010WO2010084197A1 Methods for producing mixtures of antibodies
07/29/2010WO2010084186A1 Salts and polymorphs of a kinesin inhibitor compound
07/29/2010WO2010084157A2 Multifunctional stealth nanoparticles for biomedical use
07/29/2010WO2010084097A1 Spiroindolinone derivative prodrugs
07/29/2010WO2010083870A1 Novel heterocyclic compounds for use as metap-2 inhibitors
07/29/2010WO2010083728A1 Nanoparticle formulated glycolipid antigens for immunotherapy
07/29/2010WO2010083720A1 Optical pure quinazoline compounds
07/29/2010WO2010083649A1 Bisarylurea derivatives and their use
07/29/2010WO2010083617A1 Pyrazolopyrimidines as protein kinase inhibitors
07/29/2010WO2010065512A3 Compounds for treating proliferative disorders
07/29/2010WO2010055148A3 Dosage of oligonucleotides suitable for the treatment of tumors
07/29/2010WO2010044585A3 Piperidine compounds, pharmaceutical composition comprising the same and its use
07/29/2010WO2010042925A3 Compositions and methods for treating alcohol use disorders, pain and other diseases
07/29/2010WO2010042919A3 Method of making a vaccine
07/29/2010WO2010041140A3 Treatment of proliferative disorders with a death receptor agonist
07/29/2010WO2010039920A3 Boldine compounds for promoting bone growth
07/29/2010WO2010020307A3 Indazole-5-carboxylic acid hydrazide derivatives
07/29/2010US20100192240 Regulation of expression of pi3kbeta protein in tumors
07/29/2010US20100190962 Novel serpentine transmembrane antigens expressed in human cancers and uses thereof
07/29/2010US20100190867 Stable and bioavailable compositions of isomers of lycopene for skin and hair
07/29/2010US20100190858 Pharmaceutical Formulations Containing Lipoic Acid Derivatives
07/29/2010US20100190856 Novel Polyhydroxylated Compounds as Fatty Acid Synthase (FASN) Inhibitors
07/29/2010US20100190850 Water-soluble binuclear nitrosyl iron complexes with natural aliphatic thiolyls possessing cytotoxic, apoptotic and no-donor activity
07/29/2010US20100190845 Method of treating cancer using atp synthase inhibitors
07/29/2010US20100190843 Tubulin Isotype Screening in Cancer Therapy Using Halichondrin B Analogs
07/29/2010US20100190838 Connective Tissue Growth Factor Fragments and Methods and Uses Thereof
07/29/2010US20100190830 (3-Amino-1,2,3,4-Tetrahydro-9H-Carbazol-9-yl)-Acetic Acid Derivatives
07/29/2010US20100190827 treating diseases responsive to cannabinoid receptor antagonism; using particular crystallization conditions, a novel stable crystalline form called form II is obtained
07/29/2010US20100190826 Benzimidazole derivative
07/29/2010US20100190812 Nilotinib hcl crystalline forms
07/29/2010US20100190811 Pyrimidine derivatives and compositions as c-kit and pdgfr kinase inhibitors
07/29/2010US20100190804 Macrocyclic compounds and their use as kinase inhibitors
1 ... 658 659 660 661 662 663 664 665 666 667 668 669 670 671 672 673 674 675 676 677 678 ... 2211